We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$121M
2
MDT icon
Medtronic
MDT
+$20.5M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$17.3M
4
LIN icon
Linde
LIN
+$15.1M
5
MRNA icon
Moderna
MRNA
+$12.2M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17.5M
2
MSFT icon
Microsoft
MSFT
+$12.3M
3
AAPL icon
Apple
AAPL
+$12.2M
4
AMZN icon
Amazon
AMZN
+$5.77M
5
META icon
Meta Platforms (Facebook)
META
+$5.08M

Sector Composition

Rank Sector Weight
1 Technology 23.96%
2 Healthcare 12.46%
3 Financials 12.39%
4 Consumer Discretionary 12.33%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
2551
ANI Pharmaceuticals
ANIP
$1.72B
$95.2K ﹤0.01%
+2,900
New +$90.2K
BASE
2552
DELISTED
Couchbase
BASE
$95K ﹤0.01%
+3,054
New +$112K
CTSO icon
2553
Cytosorbents Corp
CTSO
$22.8M
$94.8K ﹤0.01%
+11,670
New +$94.8K
RITM icon
2554
Rithm Capital
RITM
$5.79B
$94.7K ﹤0.01%
8,605
-345
-4% -$3.54K
FOR icon
2555
Forestar Group
FOR
$1.51B
$94.3K ﹤0.01%
5,063
– –
CMBM
2556
DELISTED
Cambium Networks
CMBM
$94.2K ﹤0.01%
+2,603
New +$103K
IPSC icon
2557
Century Therapeutics
IPSC
$349M
$94K ﹤0.01%
+3,737
New +$101K
PINC
2558
DELISTED
Premier
PINC
$93.8K ﹤0.01%
2,419
-97
-4% -$3.58K
ESPR
2559
DELISTED
Esperion Therapeutics
ESPR
$93.7K ﹤0.01%
7,777
– –
QTTB icon
2560
Q32 Bio
QTTB
$458M
$93.7K ﹤0.01%
+662
New +$84.3K
URGN icon
2561
UroGen Pharma
URGN
$2.34B
$93.6K ﹤0.01%
+5,563
New +$88.2K
RFL icon
2562
Rafael Holdings
RFL
$102M
$93.3K ﹤0.01%
3,079
– –
LXRX icon
2563
Lexicon Pharmaceuticals
LXRX
$1.04B
$93.2K ﹤0.01%
+19,371
New +$79.5K
CIVB icon
2564
Civista Bancshares
CIVB
$595M
$93K ﹤0.01%
4,004
+1,663
+71% +$38.2K
EWCZ
2565
DELISTED
European Wax Center
EWCZ
$92.7K ﹤0.01%
+3,309
New +$82.7K
SYRE icon
2566
Spyre Therapeutics
SYRE
$8.98B
$92.3K ﹤0.01%
+465
New +$81.3K
CVLG icon
2567
Covenant Logistics
CVLG
$880M
$92.3K ﹤0.01%
+6,674
New +$74.7K
KALV
2568
DELISTED
KalVista Pharmaceuticals
KALV
$92K ﹤0.01%
5,274
+236
+5% +$4.78K
FHTX icon
2569
Foghorn Therapeutics
FHTX
$385M
$91.5K ﹤0.01%
+6,569
New +$72.7K
TNYA icon
2570
Tenaya Therapeutics
TNYA
$164M
$91.5K ﹤0.01%
+4,431
New +$95.2K
MSON
2571
DELISTED
Misonix Inc
MSON
$91.2K ﹤0.01%
+3,606
New +$89.2K
INST
2572
DELISTED
Instructure Holdings, Inc.
INST
$91.2K ﹤0.01%
+4,038
New +$86.1K
EBTC
2573
DELISTED
Enterprise Bancorp
EBTC
$91.2K ﹤0.01%
+2,537
New +$84.9K
LAZ icon
2574
Lazard
LAZ
$4.43B
$91.1K ﹤0.01%
1,989
-117
-6% -$5.46K
BOLT icon
2575
Bolt Biotherapeutics
BOLT
$6.17M
$91K ﹤0.01%
+360
New +$102K
101 102
103
104 105

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
PCM
Payne Capital Management New York $331M AUM 19.65% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.